Nanomix Corp (NNMX) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nanomix Corp  (NNMX)


Nanomix's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nanomix's ROI in the fourth quarter of 2022?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Nanomix Corp's return on investment (ROI) in its fourth quarter of 2022

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -4 -3 -4 -3 -18
Return On Investment (TTM) - - - - -
NNMX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -11 -10 -11 -9

NNMX Company Profile >> Back to NNMX Roi Comparisons >> See Annual NNMX Return On Investment



Return On Investment NNMX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Nanomix's IV. Quarter Investments $ -4 Millions NNMX's Balance sheet
Nanomix's IV. Quarter Income $ -3 Millions Quarterly NNMX's Income Statement
NNMX's Income by Division See NNMX's Income by Division


NNMX Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -4 -18 -9 -8 -4
Y / Y Investment Growth - - - - -
Net Income in Millions -12 -9 -1 -4 -4
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NNMX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NNMX's Competitors
Subscribers only: Roi for Nanomix's Suppliers
Subscribers only: Return On Investment for NNMX's Customers

Other Ratios
NNMX's Roa NNMX's Inventory Turnover Ratio NNMX's Growth Rates NNMX's Dividend Statistics
NNMX's Profitability Ratios NNMX's Asset Turnover Ratio NNMX's Dividend Growth
NNMX's Roe NNMX's Valuation Ratios NNMX's Financial Strength Ratios NNMX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI
Inhibitor Therapeutics Inc   567.34 %
Gsk Plc  226.50 %
Theravance Biopharma inc   223.26 %
Ir med Inc   138.63 %
Galmed Pharmaceuticals Ltd   132.85 %
Molecular Templates Inc   115.34 %
Chimerix Inc   111.85 %
Gyre Therapeutics Inc   108.12 %
Talphera Inc   97.84 %
Opus Genetics Inc   79.52 %

Date modified: 2026-09-08T15:10:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.